Nitric Oxide–Dependent Activation of P53 Suppresses Bleomycin-Induced Apoptosis in the Lung
暂无分享,去创建一个
[1] M. Tang,et al. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. , 2000, Journal of the National Cancer Institute.
[2] P. Hainaut,et al. Nitric oxide nitrates tyrosine residues of tumor-suppressor p53 protein in MCF-7 cells. , 2000, Biochemical and biophysical research communications.
[3] B. Brüne,et al. p53 accumulation in apoptotic macrophages is an energy demanding process that precedes cytochrome c release in response to nitric oxide , 1999, Oncogene.
[4] K. Okudela,et al. The role of p53 in bleomycin-induced DNA damage in the lung. A comparative study with the small intestine. , 1999, The American journal of pathology.
[5] M. Scheffner,et al. Activation of the Cell Death Program by Nitric Oxide Involves Inhibition of the Proteasome* , 1999, The Journal of Biological Chemistry.
[6] K. Miyazono,et al. Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation , 1999, The EMBO journal.
[7] A. Wyllie,et al. P53-dependent and -independent links between DNA-damage, apoptosis and mutation frequency in ES cells , 1999, Oncogene.
[8] M. Asada,et al. p21Cip1/WAF1 is important for differentiation and survival of U937 cells , 1998, Leukemia.
[9] D. McConkey,et al. Biochemical determinants of apoptosis and necrosis. , 1998, Toxicology letters.
[10] D. Lane,et al. Cancer: Awakening angels , 1998, Nature.
[11] A. Boobis,et al. Pulmonary fibrosis correlates with duration of tissue neutrophil activation. , 1998, American journal of respiratory and critical care medicine.
[12] D. Harrison,et al. p53‐independent DNA repair and cell cycle arrest in embryonic stem cells , 1998, FEBS letters.
[13] M. Albert,et al. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.
[14] R. Hynes,et al. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. , 1998, The Journal of clinical investigation.
[15] T. McDonnell,et al. Bcl-2 inhibits p53 nuclear import following DNA damage , 1997, Oncogene.
[16] K. Kinzler,et al. A model for p53-induced apoptosis , 1997, Nature.
[17] M. Greaves,et al. Absence of p53 permits propagation of mutant cells following genotoxic damage , 1997, Oncogene.
[18] C. Nathan,et al. Nitric oxide and macrophage function. , 1997, Annual review of immunology.
[19] K. Kuwano,et al. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. , 1997, American journal of respiratory cell and molecular biology.
[20] C. Vogelmeier,et al. Oxidant-protease interaction in the lung. Prospects for antioxidant therapy. , 1996, Chest.
[21] R. Hamilton,et al. Asbestos induces apoptosis in human alveolar macrophages. , 1996, The American journal of physiology.
[22] R. Iyer,et al. Silica-induced apoptosis mediated via scavenger receptor in human alveolar macrophages. , 1996, Toxicology and applied pharmacology.
[23] M. Tang,et al. Preferential Formation of Benzo[a]pyrene Adducts at Lung Cancer Mutational Hotspots in P53 , 1996, Science.
[24] C. Haslett,et al. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. , 1996, Journal of immunology.
[25] J. Piette,et al. Anti‐apoptotic activity of low levels of wild‐type p53. , 1996, The EMBO journal.
[26] J. Lotem,et al. Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] K. Kuwano,et al. P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. , 1996, American journal of respiratory and critical care medicine.
[28] J. Savill,et al. What role does apoptosis play in progression of renal disease? , 1996, Current opinion in nephrology and hypertension.
[29] C. Harris,et al. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Hamilton,et al. Bleomycin induces apoptosis in human alveolar macrophages. , 1995, The American journal of physiology.
[31] T. Taniguchi,et al. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes , 1995, Nature.
[32] C. Nathan,et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.
[33] J. Ahearn,et al. Novel packages of viral and self-antigens are generated during apoptosis , 1995, The Journal of experimental medicine.
[34] K. Dameron,et al. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.
[35] C J Kemp,et al. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. , 1994, Cancer research.
[36] P. Baeuerle,et al. Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.
[37] D. Housman,et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.
[38] C. Purdie,et al. Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.
[39] Scott W. Lowe,et al. p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.
[40] D. Lane. A death in the life of p53 , 1993, Nature.
[41] C. Haslett,et al. Phagocyte recognition of cells undergoing apoptosis. , 1993, Immunology today.
[42] S. Ben‐Sasson,et al. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.
[43] J Savill,et al. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. , 1992, The Journal of clinical investigation.
[44] D. Lane,et al. p53, guardian of the genome , 1992, Nature.
[45] D. Petering,et al. Properties of redox-inactivated bleomycins. In vitro DNA damage and inhibition of Ehrlich cell proliferation. , 1992, Biochemical pharmacology.
[46] B. Vogelstein,et al. Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.
[47] R. Crystal. Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention. , 1991, The American journal of medicine.
[48] I Nicoletti,et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.
[49] L. Strong,et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.
[50] D. Sem,et al. Intracellular DNA strand scission and growth inhibition of Ehrlich ascites tumor cells by bleomycins. , 1990, Cancer research.
[51] D. White,et al. Bleomycin-induced pulmonary toxicity. , 1990, Clinics in chest medicine.
[52] S. Orrenius,et al. Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. , 1989, Journal of immunology.
[53] D. Hyde,et al. Effects of repeated administration of N-acetyl-L-cysteine on sulfhydryl levels of different tissues and bleomycin-induced lung fibrosis in hamsters. , 1988, The Journal of laboratory and clinical medicine.
[54] S. Hecht. DNA strand scission by activated bleomycin group antibiotics. , 1986, Federation proceedings.
[55] R. Crystal,et al. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. , 1984, The New England journal of medicine.
[56] R. Crystal,et al. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). , 1984, The New England journal of medicine.
[57] V. Devita,et al. Cancer : Principles and Practice of Oncology , 1982 .
[58] K. Pennline,et al. Alveolar macrophage--induced suppression of the immune response. , 1979, Advances in experimental medicine and biology.
[59] B. Starcher,et al. Increased elastin and collagen content in the lungs of hamsters receiving an intratracheal injection of bleomycin. , 2015, The American review of respiratory disease.